166 related articles for article (PubMed ID: 11860349)
1. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours.
Nijsen JF; van het Schip AD; Hennink WE; Rook DW; van Rijk PP; de Klerk JM
Curr Med Chem; 2002 Jan; 9(1):73-82. PubMed ID: 11860349
[TBL] [Abstract][Full Text] [Related]
2. Radioactive microspheres in therapeutics.
Sinha VR; Goyel V; Trehan A
Pharmazie; 2004 Jun; 59(6):419-26. PubMed ID: 15248454
[TBL] [Abstract][Full Text] [Related]
3. Intra-Arterial Radionuclide Therapies for Liver Tumors.
Bozkurt MF; Salanci BV; Uğur Ö
Semin Nucl Med; 2016 Jul; 46(4):324-39. PubMed ID: 27237442
[TBL] [Abstract][Full Text] [Related]
4. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.
Wong CY; Savin M; Sherpa KM; Qing F; Campbell J; Gates VL; Lewandowski RJ; Cheng V; Thie J; Fink-Bennett D; Nagle C; Salem R
Cancer Biother Radiopharm; 2006 Aug; 21(4):305-13. PubMed ID: 16999596
[TBL] [Abstract][Full Text] [Related]
5. A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization.
Pasciak AS; Bourgeois AC; Bradley YC
J Nucl Med; 2016 Jul; 57(7):1020-6. PubMed ID: 26912424
[TBL] [Abstract][Full Text] [Related]
6. 18F-labeled resin microspheres as surrogates for 90Y resin microspheres used in the treatment of hepatic tumors: a radiolabeling and PET validation study.
Selwyn RG; Avila-Rodriguez MA; Converse AK; Hampel JA; Jaskowiak CJ; McDermott JC; Warner TF; Nickles RJ; Thomadsen BR
Phys Med Biol; 2007 Dec; 52(24):7397-408. PubMed ID: 18065846
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
Ferro-Flores G; Arteaga de Murphy C
Adv Drug Deliv Rev; 2008 Sep; 60(12):1389-401. PubMed ID: 18547675
[TBL] [Abstract][Full Text] [Related]
8. Microsphere radioembolization of liver malignancies: current developments.
Bult W; Vente MA; Zonnenberg BA; Van Het Schip AD; Nijsen JF
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):325-35. PubMed ID: 19521312
[TBL] [Abstract][Full Text] [Related]
9. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.
Giammarile F; Bodei L; Chiesa C; Flux G; Forrer F; Kraeber-Bodere F; Brans B; Lambert B; Konijnenberg M; Borson-Chazot F; Tennvall J; Luster M;
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1393-406. PubMed ID: 21494856
[TBL] [Abstract][Full Text] [Related]
10. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
11. [Nuclear medicine techniques for selective internal radiotherapy of liver cancer].
Staanum PF; Arveschoug AK; Kramer SM; Nielsen JE; Nielsen DT; Ott P; Grønbæk H; Villadsen GE
Ugeskr Laeger; 2017 Jan; 179(1):. PubMed ID: 28074772
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors.
Van De Wiele C; Defreyne L; Peeters M; Lambert B
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):317-24. PubMed ID: 19521311
[TBL] [Abstract][Full Text] [Related]
13. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy.
Sharma RA; Van Hazel GA; Morgan B; Berry DP; Blanshard K; Price D; Bower G; Shannon JA; Gibbs P; Steward WP
J Clin Oncol; 2007 Mar; 25(9):1099-106. PubMed ID: 17369573
[TBL] [Abstract][Full Text] [Related]
14. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
[TBL] [Abstract][Full Text] [Related]
15. Yttrium-90 resin microspheres and their use in the treatment of intrahepatic cholangiocarcinoma.
Filippi L; Schillaci O; Cianni R; Bagni O
Future Oncol; 2018 Apr; 14(9):809-818. PubMed ID: 29251517
[TBL] [Abstract][Full Text] [Related]
16. [Selective internal radiotherapy (radioembolization) and radiation therapy for HCC--current status and perspectives].
Hilgard P; Müller S; Hamami M; Sauerwein WS; Haberkorn U; Gerken G; Antoch G
Z Gastroenterol; 2009 Jan; 47(1):37-54. PubMed ID: 19156591
[TBL] [Abstract][Full Text] [Related]
17. Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
Wong CY; Salem R; Qing F; Wong KT; Barker D; Gates V; Lewandowski R; Hill EA; Dworkin HJ; Nagle C
J Nucl Med; 2004 Nov; 45(11):1892-7. PubMed ID: 15534060
[TBL] [Abstract][Full Text] [Related]
18. Radionuclide therapy in oncology: repeated administrations of high dose rate radiopharmaceuticals.
Palmedo H; Bucerius J
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1556. PubMed ID: 15372210
[No Abstract] [Full Text] [Related]
19. Selective internal radiation therapy: quantifying distal penetration and distribution of resin and glass microspheres in a surrogate arterial model.
Jernigan SR; Osborne JA; Mirek CJ; Buckner G
J Vasc Interv Radiol; 2015 Jun; 26(6):897-904.e2. PubMed ID: 25891507
[TBL] [Abstract][Full Text] [Related]
20. State of the art: radiolabeled microspheres treatment for liver malignancies.
Deleporte A; Flamen P; Hendlisz A
Expert Opin Pharmacother; 2010 Mar; 11(4):579-86. PubMed ID: 20163269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
